|
|
|
|
|
|
|
|
 |
| Scientific Program |
 |
|
|
Hall A |
|
|
|
|
08:30-10:00 |
Debates in Lipid Management
Chair: E. Standl, Germany & R. Bitzur, Israel |
|
08:30-08:35 |
Introduction |
|
|
08:35-08:55
08:55-09:15 |
Intolerance to statin drugs
Mechanisms of intolerance: R. Bitzur, Israel
How to manage the problem: D. Neely, UK |
|
09:15-09:35
09:35-09:55
09:55-10:00 |
Residual CV risk in diabetes
We have reached the limit: M. Mosseri, Israel
There is still potential: N. Marx, Germany
Discussion |
|
10:0:00-10:30 |
Coffee Break |
|
|
10:30-12:00 |
Future Therapeutic Approaches
Chairs: R. Gomis, Spain & S. Del Prato, Italy |
|
10:30-10:35 |
Introduction |
|
10:35-10:55
|
ORIGIN trial-
The results/ A critical comment: S. Del Prato, Italy |
|
10:55-11:15
|
Translating the ORIGIN results into clinical practice
M. Hanefeld, Germany |
|
11:15-11:35
11:35-12:00 |
Future GLP-1R- Do they differ?
A. Garber, USA
Discussion |
|
|
|
|
|
|
|
WebStudio.co.il